chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The subject, a 29 year old female, with a history of high blood pressure, environmental allergies experienced swelling, pruritic, redness and inflammation of the right arm on 13Jun00 following a fifth vaccination with Anthrax vaccine lot number FAV048B on 13Jun00. No other vaccinations were received. Concomitant medications reported were Micronor, Allegra, Ziac, and Daily Vitamins. No pain was associated with the events. The events resolved within 4 to 5 days. There were no treatment drugs to report. The committee cases assessment form was not provided. Additional information will be provided as it becomes available. Reported on 09Feb01.
Started 3 days ago (7/14/17) with rash on legs and now on abd and arms. Urticarial erythematous papules and plaques coalescing on legs erythematous papules on arms and abdomen. No involvement of palms or soles of feet. No blisters, no execration, no itch, no temp, no mucosal involvement. Looks very consistent of urticarial drug reaction. Exanthematous but no new meds.
4 x 6 cm localized rash on left thigh with induration warmth, occurred less than 24 hours after vaccination.
Information has been received from a Nurse Practitioner concerning a 13 year old female with a history of lightheadedness who on 25-MAY-2007 was vaccinated with the first dose of Gardasil 0.5 ml. Concomitant therapy included DTaP (unspecified) and Menactra. The physician reported that the patient fainted the day after receiving the vaccine. The patient was sitting and fainted when she stood up. The patient sought unspecified medical attention. As of 30-MAY-2007 the patient had recovered. Additional information has been requested.
soreness at arm; woke up with fever 100.1 F.; scratchy throat; Sick; Sore throat, scratchy throat; cough; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), OROPHARYNGEAL PAIN (Sore throat, scratchy throat), COUGH (cough), PAIN IN EXTREMITY (soreness at arm) and THROAT IRRITATION (scratchy throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced ILLNESS (Sick), OROPHARYNGEAL PAIN (Sore throat, scratchy throat), COUGH (cough) and THROAT IRRITATION (scratchy throat). On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness at arm) and PYREXIA (woke up with fever 100.1 F.). At the time of the report, ILLNESS (Sick), OROPHARYNGEAL PAIN (Sore throat, scratchy throat), COUGH (cough), PAIN IN EXTREMITY (soreness at arm), THROAT IRRITATION (scratchy throat) and PYREXIA (woke up with fever 100.1 F.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable
I tested positive for Covid on August 27. I have been quite ill. I received the monoclonal antibody infusion on September 1
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 08/26/2021. PATIENT FULLY VACCINATED ON 03/18/2021.
Missed Second Dose ( Beyond 42 days); Tired; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), PRODUCT DOSE OMISSION ISSUE (Missed Second Dose ( Beyond 42 days)) and FATIGUE (Tired) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced DIZZINESS (Dizzy). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed Second Dose ( Beyond 42 days)) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizzy), PRODUCT DOSE OMISSION ISSUE (Missed Second Dose ( Beyond 42 days)) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Shot #1: (10Apr07) No reaction.  Shot #2 (24Apr07) Hard knot in left arm, reddened patch approx 2" across. Started having joint pain in left elbow area, sharp pains resembling a pinched nerve in upper part of arm, tingling in fingertips of left arm.  Shot#3: (18May07) Larger hard knot in left arm, reddened area now 4" in diameter, continued pain in left elbow joint, sharp intermittent pains in upper left arm, increased tingling in left fingertips/hand, feeling sluggish, achy.
Since the first vaccination on 2/04/2021, I have had intense itching episodes whole body. I have had a rash on my hand mainly on my left side. These itching episodes have continued since the second vaccine on 3/3/2021.  I also had intense body and joint pain which began about 8 hours after the second Moderna injection which continued for 12 hours or so.  I understood that this was likely to occur however, after the intense pain and soreness subsided, I am concerned that the joint pain remains.  I am in hopes that is subsides soon. I was not experiencing joint pain like I am having now prior to the vaccine.  These things that I am experiencing have not led me to the doctor yet. I am in hopes that the itching and the joint pain will subside.
Sore arm the first day, fever and headache the second day. Missed a day of work, but a small price to pay for the vaccine. General weakness and chills. Extremely sore muscles, I have muscle tension, and this definitely exacerbated it.
Received DTAP, Hib, Ipv, Prevnar 7/25/05. Nextam had heat seizure. General seizure 7/26/06. Since has had many seizures, with many meds and ketogenic diet. She has severe developmental delay. She has been dx'd with Drants Syndrome. She currently has seizures that cause apnea and require intubation. 10/16/06 Received medical records from hospital which reveal patient had known seizure disorder, Dravet's Syndrome from approx 2 mo of age.  Had been admitted to hospital approx 1 mo prior to current admission for seizure control.  Was on ketogenic diet which was adjusted at that time, as well as Pb & klonopin.  Febrile at 102.7 on admit & had been seizing for approx 45 min.  Intubated for airway protection but extubated a few hours later.  Parent requested G-tube placement as patient failed swallow test.  She was also noted to have developmental delays, unable to stand unassisted & can't speak. Patient had vax on 7/25/05 & AE on 7/26/05 & had never recovered.  Continues to actively seize. 12/21/06 Received medical records from hospital which reveal patient admitted 7/26/05 (day after 2 mo vax) to 7/29/05 after being transferred from outlying hospital.  Breast feeding with 2 bottles of formula to supplement. Neuro consult done.  No further seizure activity while hospitalized & d/c home on 7/29/05 w/followup to be done by neuro. Final Dx: Complex febrile seizures. 02/01/2010 Still seizures. Hospitalized awaits for over 2 months.
Itching; Tongue is numb and tingling; Tongue is numb and tingling; allergic reaction; at the injection site she broke out; rashes on both arms/saw other red dots appear; Rash; This is a spontaneous report from a contactable consumer.A 18-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 26Apr2021 18:00 (Batch/Lot Number: EW0153; Expiration Date: Jul2021) as SINGLE DOSE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced rash on 27Apr2021, itching on 28Apr2021, tongue is numb and tingling on 27Apr2021, allergic reaction on 27Apr2021, she thought it was acne at first, but at the injection site she broke out on 27Apr2021, rashes on both arms/saw other red dots appear on 27Apr2021. Clarified allergic reaction as: She thought it was acne at first, but at the injection site she broke out. She has rashes on both arms. Rash seems to be spreading. Really started to show on day two and day three. Hasn't taken anything for it. She tends to break out on her arms, that's just her own body, but she saw other red dots appear that hadn't been there on her arms. She was itching last night and that was new. Is not itching as of now. She went to the hospital and was told to take Benadryl. Clarified she went to the vaccination facility, which was the hospital, and she was asked what was going on. She was not a patient of the ER and was not admitted to the hospital. Forgot to mention her tongue has been numb and tingling for a couple of days. First noticed it when she had something cold, but has persisted even without drinking something cold. Started Tuesday, 27Apr2021, night. Wondering if that is a side effect. Read in the pamphlet it is part of an allergic reaction. Read that rash is a part of a severe reaction.Outcome of all events was not recovered.  Therapeutic measures were taken as a result of all events.
This spontaneous report as received from a medical assistant and a healthcare worker refers to a female patient of unknown age. The patient was vaccinated with dose 1, dose 2 and dose 3 GARDASIL (lot # 673256/0629AE, exp date 16-DEC-2014, reported by a healthcare worker) on 20-JAN-2012, 24-MAY-2012 and 20-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse symptoms reported. This is one of two reports concerning a couple of twin sisters received from the same source. Additional information has been requested.
generalize aching,  chills with no fever, pain at the site of injection, headache, lasting for one day. Tylenol helps with the symptoms.
This spontaneous report as received from a health care worker refers to a female patient of unknown age. The patients pertinent medical history and drug reactions/allergies were unspecified by the reporter. On 31-MAR-2014 the patient was vaccinated with GARDASIL lot # J013324, expire date 12-FEB-2016, intramuscular. No concomitant medications were reported. On 31-MAR-2014, few minutes after the therapy the patient fainted. The sought medical attention was not reported. After few minutes (31-MAR-2014) the patient recovered from the adverse event fainted. It was reported that the lot check was requested. This is one of the two report received from the same reporter link (1404USA004213). Additional information has been requested.
brain fogginess; Short term memory loss; tired; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient not pregnant received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Right arm on 18Jan2021 at 01:00 PM as a single dose for COVID-19 immunisation, lot number: unknown. Medical history included high blood pressure, asthma, hypothyroidism, prediabetes and allergies to penicillin (possibly), clindamycin, levofloxacin (LEVAQUIN) and environmental allergies. Concomitant medications in two weeks prior to the vaccination included high blood pressure, asthma, prediabetes and thyroid medications. Prior to vaccination the patient was not diagnosed with COVID-19. Patient did not receive other vaccine in four weeks prior to the COVID vaccine. On 19Jan2021 at 09:00 AM patient experienced short term memory loss, repeated same sentences many times in short amount of time (>7x), tired and brain fogginess. No treatment received for the events. It was also reported that post vaccination the patient had been tested for COVID-19. Test Name: PCR (Nasal Swab) on 20Jan2021 with negative results. Patient recovered from the events on unknown date.  Information about lot/batch number has been requested.
Rash starting from the vaccine site and spreading all around the body. The type of rash is consistent with previously experienced reactions during the course of previous viral infections. The rash disappeared in leas than 2 days with no medication taken and consistent with previous experiences.
I took a .5mg Lorazepam at 11pm the night of the injection and about 4am I was very cold and the room temp. was 78 degrees. I got up to go to the bathroom and I was so cold and shaking so bad I could not walk and about fell. After getting back in bed my wife covered me with two heavy blankets. I got up at 9am after not sleeping all night and I felt bad. I went out side for a minute in 54 degrees and  when I got in the house I was cold and shaking. I stayed in the house all day and at 11pm i tool a lorazepam and sleep all night to 8am. Today I feel better and not cold.
My head started feeling not clear. I began monitoring my temperature & I noticed an increase. My stomach became upset and my temperature continued to climb to 102.8. My head ached for about 6 hours. I had chills & my stomach was cramping. I had the shakes and I attempted to reach out to my doctor. As I waited to hear from my doctor, most of my symptoms subsided the next day.
Uncontrollable menstrual cycle. Started heavily bleeding/clots within 1 week of first dose. My second dose was administered on 09/03/2021. Since then I have had 3 periods when I am on medication to keep me from having a period due to Endometriosis. After a month of on-and-off cramping, pain, and bleeding I was admitted to hospital for worsening of my Endometriosis as the medication that I was on (which had been working) started to fail post vaccination. Now almost two months post vaccination, I am preparing to have another surgery to remove possible new growths and scar tissue from worsening endometriosis and debilitating periods.
Fever with temp 98.8-101.3. Mom denies irritability or changes in rash.  Advised Tylenol per weight dosage, tepid bath, hydration, continue to monitor symptoms and inform clinic of changes.  Notified provider per message and will f/u with mom with further recommendations.
sciatic nerve diagnosed as inflamed only left leg and shot provided left arm; This is a spontaneous report from a contactable nurse (patient). A 62-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration in right arm on 08Jan2021 14:00 at a single dose for Covid-19 immunization. Medical history included blood pressure. Concomitant medication included unspecified blood pressure medication. On 09Jan2021 at 2pm, sciatic nerve was diagnosed as inflamed only on left leg and shot (treatment) was provided in left arm. Patient visited emergency room/department, methylprednisolone sodium succinate (PF) was given as treatment. The event was reported as non-serious, patient was not hospitalized. The patient underwent lab tests which included COVID-19 Nasal RT-PCR: negative on 25Jan2021 (Nasal Swab). Outcome of the event was recovering.    Information on the lot/batch number has been requested.
Mild injection site soreness; Mild headache; Tired; This is a spontaneous report from a contactable consumer (patient). A 59-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247, Expiration date not reported), via an unspecified route of administration, administered in left arm on 22Feb2021 13:15 (at the age of 59 years) as dose 1, single for COVID-19 immunization. Medical history included acid reflux, Hot flashes, and codeine sensitive from an unknown date and unknown if ongoing. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination: yes. Patient was on unspecified concomitant medication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Feb2021 06:00, the patient experienced mild injection site soreness, mild headache, and tired. Patient did not receive any treatment for the adverse events. Patient assessed the case as non-serious. The outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Symptoms:  Headache, a 5 out of ten with ten being the worst.  Legs cramping and going stiff.  Hips and legs severely fatigued and unable to walk more than five minuted. Vertigo Severe fatigue, difficulty staying awake even after a full nights sleep.  This lasted two weeks after the vaccine and is continuing.
This spontaneous report was received from a registered nurse and refers to multiple patients of unspecified age and gender. No pertinent concurrent conditions or medical history was reported. On multiple unspecified dates, the patients were vaccinated with an unspecified amount of improperly stored doses of PEDVAXHIB, intramuscular injection (lot # L042836, with expiration date of 24-AUG-2018; exact dose and route of administration were not reported). There were no concomitant therapies reported. The doses of the vaccine were exposed to a temperature excursion of -0.3 degrees Celsius for a total time frame of 22 hours on an unspecified date. A Digital Data Logger was involved. No adverse effects were reported. There were no previous temperature excursions. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient at the time of vaccination on 3-8-21 has having issues with shortness of breath and edema consistent with congestive heart failure, the following day on 3-9-21, he was having more issues with shortness of breath, tachycardia, low O2 saturation.  He was given meds in the clinic and monitored until he was feeling better with increased O2 sats.  He was found unresponsive on his housing unit one hour later and failed to respond to resuscitation efforts and was pronounced expired at 1047.
Mistakenly gave IPV ID instead of PPD. Gave IPV (Aventis Pastuer X1040 exp 09/26/06)ID right forearm. When mistake noted gave intended PPD to left forearm (Tubersol Aventis Pasteur C1710AA exp 03/03/06) No reactions occurred at time of administration. No adverse reactions occurred.
I received the shot on 05/01/2021. For a couple of days I was feeling like I was catching a cold and was very tired. Tuesday morning I was having trouble getting out of bed,walking and going to the bathroom.I called my Dr. and she prescribed a pain medication and a muscle relaxer. A couple of days after I went to her office. She gave me more medication and referral for aqua therapy. As of today i am still unable to sit or stand for very long. There are nights that I can't sleep. All of the pain i am referring to is on the right side of my body.
Bone pain sharp stabbing pain inside of my bones. I?m day 5 after injection and have now tested positive for Covid. I was healthy before injection symptoms started 24 hours after injection.
I don't know if this would be considered an adverse reaction to the vaccine, or being a recovered COVID19 patient, but I started feeling unwell on the afternoon of May 16th, a little worse the next day with a sore throat, congestion, runny nose and burning eyes. On Tuesday the 18th I had a slight fever, so I went to the walk-in clinic to be assessed and tested for COVID19 to make sure it wasn't that. The APN explained that I was experiencing seasonal/environmental allergies after having worked outside on May 16th and 17th. I have never had allergies before and it felt like I was coming down with a cold of some kind, so I wanted to be assessed and ensure I wouldn't get anyone else sick. The APN agreed the slight fever (99.6) was atypical and she understood why I came in. She prescribed allergy eye drops and nasal spray and told me to take an OTC allergy medication. I have continued to experience some allergy symptoms (runny nose, congestion, burning eyes) even after 2 weeks of taking medication. I am unsure if my immune system has changed as a result of having COVID19 in April 2020 or a reaction to the vaccine.
Hospitalized (11.16.21 -discharged 11/20/21; COVID-19 positive (11.16.21); Fully vaccinated   HOSPITAL COURSE: Patient is a 69M  with a history of pulmonary fibrosis and right prosthetic knee infection with MSSA status post right total knee replacement in July.  He completed 6 weeks IV cefazolin then transition to cephalexin.  He had relapse infection with additional OR on October 20th.  Intraoperative cultures grew Serratia and patient currently is on cefepime through December 7th.  He follows with Dr. from pulmonary and currently is not on home oxygen or steroids due to underlying knee infection.     He presented to Emergency Department with 2 days of acute worsening in his shortness of breath.  Minimal exertion makes the symptoms worse.  He has productive cough with chills but no fever.  Patient has received full vaccinations for COVID-19 (J and J).  On arrival to emergency department he was found to be hypoxic with oxygen saturation 70% room air.  Supplemental oxygen was placed with improvement to mid 90s.  He did undergo CT angiogram thorax which was negative for pulmonary embolism but had new superimposed mosaic attenuation throughout both lung fields question developing pulmonary edema or infectious etiology.  His BNP was normal, COVID-19 was not detected, procalcitonin was normal.   He was given 20 mg IV Lasix and transferred to another facility for ongoing care.   Film array was ordered which eventually showed positive for COVID-19.  He was started on Decadron 6 mg daily with plan to complete a 10 day treatment course.  He also received Remdesivir for 5 days.  He was seen by infectious disease who recommended continuing cefepime through 12/07/2021.   Pulmonary medicine recommended to continue Symbicort inpatient and albuterol p.r.n..  He is scheduled for outpatient follow-up with the Pulmonary office on 12/28   He continues to remain stable and required 3 L of oxygen with rest and 4 L of O2 with ambulation.  He will be out of COVID isolation on 11/24/2021   He was discharged home in stable condition on 11/20/2020 CONSULTS / RECOMMENDATION:   Consult Orders (From admission, onward)    IP CONSULT TO INFECTIOUS DISEASES      Provider:  MD   IP CONSULT TO PULMONOLOGY      Provider:  MD
Kinrix administered to a 10 months-old; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 10-month-old female patient who received DTPa-IPV (Kinrix) (batch number 2KL4K, expiry date 9th November 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th February 2023, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 7th February 2023, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 15-FEB-2023 Reporter's comment: The reporter was a nurse. The reporter reported that the10 month old baby patient received Kinrix vaccine. The reporter wanted to know for any expected adverse event or risk associated with the vaccination. The reporter did consent to follow up. Additional supportive information: The patient received Kinirix who was younger than the indicated age which led to inappropriate age at vaccine administration.